Sinclair Pharma PLC ORD 1P/ GB0033856740 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-GBX | - | - Turnover(GBP): - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
15/03/2021
Strategic partner Novicell and Agillic are pursuing international growth together
GlobeNewswire
30/10/2019
Dermal Filler Device Pipeline Study 2019: Analysis of Devices under Development, Companies, Developm...
GlobeNewswire
22/03/2019
Global Aesthetic Threads Markets, 2019-2024 - High Cost of Treatments & Uncertain Results Restrainin...
GlobeNewswire
25/09/2018
Global Medical Aesthetics Market Forecast 2018-2023 - Growing Adoption of Minimally Invasive and Non...
GlobeNewswire
15/12/2017
North America and Europe Dermal Filler Market to be worth US$ 2,800.4 Mn by the end of 2026 - Future...
GlobeNewswire
25/08/2017
World Prescription Dermatological Drugs Market 2017: New Biologics and Their Uses in Dermatology / M...
GlobeNewswire
29/06/2017
Worldwide Facial Injectables Market 2017-2023 - Market is Estimated to Witness a CAGR of 10.42% with...
GlobeNewswire
09/11/2007
Statement re Sinclair Pharma plc announces appointment of Jean-Charles Tschudin as non-executive dir...
GlobeNewswire
08/11/2007
Statement re Sinclair Pharma plc announces appointment of Jean-Charles Tschudin as non-executive dir...
GlobeNewswire
16/10/2007
Sinclair Pharma plc announces US launch of Aloclair (Ameseal) oral lesion relief spray by OMNI Preve...
GlobeNewswire
27/09/2007
Sinclair Pharma plc announces Dr Reddy's Laboratories, Inc. as Sebclair marketing partner in US